2. Academic Validation
  3. The in vivo activity of olamufloxacin (HSR-903) in systemic and urinary tract infections in mice

The in vivo activity of olamufloxacin (HSR-903) in systemic and urinary tract infections in mice

  • J Antimicrob Chemother. 2001 Jul;48(1):137-40. doi: 10.1093/jac/48.1.137.
S Yoshizumi 1,  Y Takahashi,  M Murata,  H Domon,  N Furuya,  Y Ishii,  T Matsumoto,  A Ohno,  K Tateda,  S Miyazaki,  K Yamaguchi
Affiliations

Affiliation

  • 1 Department of Microbiology, Toho University School of Medicine, Tokyo. Research Department, Research & Development Division, Hokuriku Seiyaku Co., Ltd, Fukui, Japan. [email protected]
PMID: 11418525 DOI: 10.1093/jac/48.1.137
Abstract

The in vivo activity of olamufloxacin (HSR-903), a new fluoroquinolone, was evaluated and compared with ciprofloxacin, sparfloxacin and levofloxacin. Olamufloxacin was active against systemic Infection in mice inoculated with both Gram-positive and -negative bacteria. Olamufloxacin had equal efficacy for experimental urinary tract infections in mice caused by Pseudomonas aeruginosa.

Figures
Products